Optimisation of the conditions for generating human DC initiated antigen specific T lymphocyte lines in vitro

Journal of Immunological Methods

Volumn 219, Issue 1-2, 1998, Pages 69-83

  Mannering, Stuart I ^a   McKenzie, Judith L ^a   Hart, Derek N J ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Bcr abl; Dendritic cells; Media; Primary response; T lymphocyte lines; Tumour associated antigen

Indexed keywords

BCR ABL PROTEIN; CD14 ANTIGEN; CD19 ANTIGEN; TUMOR ANTIGEN;

ANTIGEN PRESENTING CELL; ARTICLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; BLOOD; CELL CULTURE TECHNIQUES; CELL DIVISION; CELL LINE; CELL SEPARATION; CULTURE MEDIA; DENDRITIC CELLS; ENTEROTOXINS; FUSION PROTEINS, BCR-ABL; HUMANS; IOHEXOL; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; PEPTIDES; PHYTOHEMAGGLUTININS; T-LYMPHOCYTES; TETANUS TOXOID;

EID: 0032192403     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(98)00125-2     Document Type: Article

References (25)

1. Ausubel L.J., Kwan C.K., Sette A., Kuchroo V., Hafler D.A. Complementary mutations in an antigen peptide allow for crossreactivity of autoreactive T-cell clones. Proc. Natl. Acad. Sci. 93:1996;15317.
2. Causey A.L., Wooten R.M., Clem L.W., Bly J.E. A serum-free medium for human primary T lymphocyte culture. J. Immunol. Meth. 175:1994;115.
3. Fearnley D.B., McLellan A.D., Mannering S.I., Hock B.D., Hart D.N.J. Isolation of human blood dendritic cells using the CMRF-44 monoclonal antibody: implications for studies on antigen presenting cell function and immunotherapy. Blood. 89:1997;3708.
4. Gambacorti-Passerini C., Grignani F., Arienti F., Pandolfi P.P., Pelicci P.G., Parmiani G. Human CD4 lymphocytes specifically recognize a peptide representing the fusion region of the hybrid protein pml/RAR alpha present in acute promyelocytic leukemia cells. Blood. 81:1993;1369.
5. Gebel H.M., Scott J.R., Parvin C.A., Rodey G.E. In vitro immunization to KLH: II. limiting dilution analysis of antigen reactive cells in primary and secondary culture. J. Immunol. 130:1983;29.
6. Hart D.N.J. Dendritic cells: unique leucocyte populations which control the primary immune response. Blood. 90:1997;3245.
7. Hart, D.N.J., Calder, V.L., 1994. Human dendritic cells: function and cytokine production. Immunopharmacology of macrophages and other antigen-presenting cells. In: Dr. Bruijnzell-Loomen (Ed.), Handbook of Immunopharmacology. p. 63.
8. Hock B.D., Starling G.C., Daniel P.B., Hart D.N.J. Characterisation of CMRF-44, a novel monoclonal antibody to an activation antigen expressed by the allostimulatory cells within peripheral blood, including dendritic cells. Immunology. 83:1994;573.
9. Hsu F.J., Benike C., Fagnoni F., Liles T.M., Czerwinski D., Taidi B., Engelman E.G., Levy R. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med. 2:1996;52.
10. Inaba K., Metlay J.P., Crowley M.T., Steinman R.M. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J. Exp. Med. 172:1990;631.
11. Inaba K., Inaba M., Naito M., Steinman R.M. Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Geurin organisms and sensitize mice to Mycobacterial antigens in vivo. J. Exp. Med. 178:1993;479.
12. Kaldjian E.P., Chen G.H., Cease K.B. Enhancement of lymphocyte proliferation assays by use of serum-free medium. J. Immunol. Meth. 147:1992;189.
13. + T-cell lines specific for HIV gp120. J. Acquired Immune Defic. Syndr. 7:1994;15.
14. + T lymphocytes respond to dendritic cells pulsed with b3a2 peptide and antigen-presenting cells exposed to b3a2 containing cell lysates. Blood. 99:1997;290.
15. Matsuno K., Ezaki T., Kudo S., Uehara Y. A life stage of particle-laden rat dendritic cells in vivo: their terminal division, active phagocytosis and translocation from the liver to the draining lymph. J. Exp. Med. 183:1996;1865.
16. McLellan A.D., Starling G.C., Hart D.N.J. Isolation of human blood dendritic cells by Nycodenz discontinuous gradient centrifugation. J. Immunol. Meth. 184:1995;81.
17. McLellan A.D., Sorg R.V., Williams L.A., Hart D.N.J. Human dendritic cells activate T lymphocytes via a CD40:CD40 ligant-dependent pathway. Eur. J. Immunol. 26:1996;1204.
18. Nijman H.W., Kleijmeer M.J., Ossevoort M.A., Oorschot V.M.J., Vierboom M.P.M., van de Keur M., Kenemans P., Kast W.M., Geuze H.J., Melief C.J.M. Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells. J. Exp. Med. 182:1995;163.
19. Panina-Bordignon P., Tan A., Termitjtelen A., Demotz S., Corradin G., Lanzavecchia A. Universally immunogenic T cell epiptopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur. J. Immunol. 19:1989;2237.
20. Pawelec G., Max H., Halder T., Bruserud O., Merl A., da Silva P., Kalbacher H. BCR/ABL leukemia oncogene fusion peptides selectively bind to certain HLA-DR alleles and can be recognized by T cells found at low frequency in the repertoire of normal donors. Blood. 88:1996;2118.
21. Romani N., Koide S., Crowley M., Witmer-Pack M., Livingstone A.M., Fantham C.G., Inaba K., Steinman R.M. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J. Exp. Med. 169:1989;1169.
22. + T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptide. Blood. 88:1996;3522.
23. Troy A., Hart D.N.J. Dendritic cells in cancer: progress towards a new cellular therapy. J. Hematother. 6:1997;523-533.
24. Williams L.A., Egner W., Hart D.N.J. Isolation and function of human dendritic cells. Int. Rev. Cytol. 153:1994;41.
25. Young J.L., Daser A., Beverley P.C.L. In vitro proliferative responses of human peripheral blood mononuclear cells to non-recall antigens. J. Immunol. Meth. 182:1995;177.